Navigation Links
Vinomis Laboratories Completes Additional Funding Round

Dietary supplement maker Vinomis Laboratories, makers of the red wine and Resveratrol-based anti-aging supplement Vindure 900, announced today that it had successfully completed a new round of funding which will be used to expand the company’s marketing, advertising, and free trial programs.

(PRWEB) May 3, 2010 -- Vinomis Laboratories, LLC, makers of the Resveratrol supplement, Vindure 900, announced today that it had successfully completed a new round of funding which will be used to expand the company’s marketing, advertising, and free trial programs. The entire round was taken up by current investors. The amount of the investment was not disclosed. Vinomis is a privately held company.

“Our investors have been very pleased with the rapid growth of the company,” noted Barry Yarkoni, CEO. “They are especially impressed with the extraordinary reorder rates from existing customers, an indication of high customer satisfaction.”

Vindure 900, Vinomis’ flagship product, is a high potency red wine based anti-aging supplement. Research at Harvard and other universities has shown that Resveratrol and other polyphenols found in red wine grapes can activate the SIRT genes, which has been shown in animal studies to play a key role in maintaining health and promoting longevity. Proprietary human studies on the ingredients in Vindure 900 have shown significant improvements in energy, endurance and memory. The company also has an exclusive patent license from Harvard Medical School.

During the past few years, a great deal of attention has been focused on Resveratrol, and it has been the focus of a number of news reports both in print and on television. Myriad stories have appeared on popular national television shows including 60 Minutes, Dr. Oz, Oprah, and Barbara Walters, focusing on research results involving Vindure 900 ingredients and their potential health benefits.

Vinomis Laboratories, LLC, is headquartered in Sewickley, PA. It was founded in 2009 by a group of physicians and business leaders dedicated to improving people's health and longevity.

# # #

Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Global Dental Laboratories Market to Exceed $14.5 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
2. Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories CRINONE(R) Progesterone Gel Product Line
3. IDEXX Laboratories Elects Joseph Vumbacco as Director
4. Sunquest Completes System-Wide Implementation at Cleveland Clinic Hospital Laboratories
5. University of Virginia Health System Medical Laboratories Selects Sunquest's Specimen Collection Solution
6. Dr. Ron Grabowski Named Director of Clinical Nutrition and Education for SpectraCell Laboratories
7. Sunquest Information Systems Supports New Meaningful Use Guidelines for Laboratories Transferring H1N1 Results
8. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal Year 2010
9. Roxane Laboratories, Inc. Announces the New Drug Application Approval of Morphine Sulfate Oral Solution CII, 100mg/5mL (20mg/mL)
10. Agilux Laboratories Announces the Launch of GLP LC/MS/MS Bioanalytical Services
11. Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services
Post Your Comments:
Related Image:
Vinomis Laboratories Completes Additional Funding Round 
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many ... the beholder, according to experts who offered insights and commentary in the current issue ... the full issue, click here . , For the American Society of Clinical ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: